HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmen Roncal Selected Research

Streptozocin (Streptozotocin)

1/2019MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmen Roncal Research Topics

Disease

7Atherosclerosis
05/2024 - 04/2010
7Peripheral Arterial Disease
01/2022 - 02/2015
6Myocardial Infarction
03/2021 - 11/2007
5Ischemic Stroke
04/2024 - 08/2017
5Thrombosis (Thrombus)
04/2024 - 06/2012
4Stroke (Strokes)
12/2023 - 08/2017
4Ischemia
10/2018 - 03/2010
4Hypoxia (Hypoxemia)
03/2015 - 03/2010
3Inflammation (Inflammations)
05/2024 - 06/2012
3Hemorrhage
08/2022 - 01/2019
3Neoplasms (Cancer)
01/2014 - 02/2011
2Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2022 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2021
2Vascular Calcification
01/2020 - 11/2018
1Atrial Fibrillation
04/2024
1Fibrosis (Cirrhosis)
01/2023
1Heart Failure
01/2023
1Infections
10/2022
1Aneurysm (Aneurysms)
05/2022
1Abdominal Aortic Aneurysm
05/2022
1Aortic Valve Stenosis (Aortic Stenosis)
01/2022
1Aortic Aneurysm (Aneurysm, Aortic)
01/2022
1Muscular Dystrophies (Muscular Dystrophy)
12/2021
1Albuminuria
05/2021
1Hematoma
01/2020
1Diabetes Mellitus
01/2019
1ST Elevation Myocardial Infarction
10/2018
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2017
1Coronary Disease (Coronary Heart Disease)
11/2017
1Brain Ischemia (Cerebral Ischemia)
08/2017
1Vascular Remodeling
02/2015
1Intermittent Claudication
02/2015
1Chronic Limb-Threatening Ischemia
02/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2014
1Necrosis
06/2013
1Reperfusion Injury
03/2010
1Disseminated Intravascular Coagulation
12/2009
1Hypertrophy
11/2007

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
05/2024 - 11/2017
4Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2015
4Matrix Metalloproteinases (MMPs)IBA
12/2021 - 02/2015
3Hemostatics (Antihemorrhagics)IBA
12/2023 - 01/2021
3Plasminogen Activator Inhibitor 1IBA
08/2022 - 02/2006
3Apolipoproteins E (ApoE)IBA
05/2021 - 04/2010
3Matrix Metalloproteinase 10 (Stromelysin 2)IBA
01/2021 - 02/2015
3ThrombinFDA Link
08/2017 - 12/2009
3Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
06/2013 - 03/2010
2FibrinIBA
12/2023 - 01/2021
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
01/2023 - 02/2015
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022 - 01/2020
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 08/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2014 - 11/2007
2Oxygen (Dioxygen)IBA
12/2010 - 03/2010
1CholesterolIBA
05/2024
1Factor XIII (Coagulation Factor XIII)IBA
12/2023
1Procollagen Type IIBA
01/2023
1Collagen Type I (Type I Collagen)IBA
01/2023
1Peptides (Polypeptides)IBA
01/2023
1procollagen type I carboxy terminal peptide (PICP)IBA
01/2023
1Plasminogen Activators (Plasminogen Activator)IBA
08/2022
1Warfarin (Coumadin)FDA LinkGeneric
08/2022
14- (4- ((3- (hydroxycarbamoyl)- 8- azaspiro(4.5)decan- 3- yl)sulfonyl)phenoxy)- N- methylbenzamideIBA
08/2022
1AnticoagulantsIBA
08/2022
1RivaroxabanIBA
08/2022
1Interleukin-6 (Interleukin 6)IBA
08/2022
1fibrin fragment D (D-dimer)IBA
05/2022
1Lipocalin-2IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
05/2021
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2021
1von Willebrand FactorIBA
01/2021
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2020
1trimethyloxamine (trimethylamine N-oxide)IBA
10/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1calcium phosphateIBA
11/2018
1Connexin 43 (Connexin43)IBA
10/2018
1HDL CholesterolIBA
11/2017
1Neuroprotective AgentsIBA
08/2017
1ChemokinesIBA
03/2015
1matrigelIBA
07/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014
1Thromboplastin (Tissue Factor)IBA
01/2014
1Transcription Factors (Transcription Factor)IBA
08/2012
1CD40 Ligand (CD40L)IBA
06/2012
1Blocking AntibodiesIBA
02/2011
1Monoclonal AntibodiesIBA
02/2011
1Cell Adhesion MoleculesIBA
02/2011
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2011
1E-SelectinIBA
02/2011
1EnzymesIBA
03/2010
1Small Interfering RNA (siRNA)IBA
03/2010
1Vascular Endothelial Growth Factor BIBA
11/2007
1Phosphotransferases (Kinase)IBA
11/2007

Therapy/Procedure

3Therapeutics
01/2023 - 01/2021
2Surgical Amputation (Amputations)
03/2021 - 11/2017
1Secondary Prevention
04/2024
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2021
1Thrombectomy
01/2021
1Carotid Endarterectomy
11/2018
1Drug Therapy (Chemotherapy)
08/2012
1Aftercare (After-Treatment)
02/2011